Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Chuei Wuei Leong"'
Autor:
Jessica Sze Chia Ng, Yi Xin Tan, Nor Amalina Ahmad Alwi, Kar Ming Yee, Ahmad Hazri Abdul Rashid, Ka-Liong Tan, Chuei Wuei Leong
Publikováno v:
Journal of Current Glaucoma Practice. 15:139-143
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0841dbdb2fef63ef73884cd923dbc872
https://doi.org/10.5005/jp-journals-10078-1319
https://doi.org/10.5005/jp-journals-10078-1319
Autor:
Alia Shaari Ahmad Shukri, Nishalini Harikrishnan, Chuei Wuei Leong, Ka-Liong Tan, Kar Ming Yee, Nalla Ramana Reddy
Publikováno v:
Generics and Biosimilars Initiative Journal. 10:113-118
Introduction/Study Objectives: A bioequivalence study was performed to compare the pharmacological profile of innovator etoricoxib (ETO) with a newly developed generic ETO, both in a 120 mg tablet formulation. A dissolution study was conducted to opt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43731f09fa0567902c74d7f41b2d9575
https://doi.org/10.5639/gabij.2021.1003.013
https://doi.org/10.5639/gabij.2021.1003.013
Autor:
Chuei Wuei Leong, Kar Ming Yee, Jeyashanthini Nalaiya, Zawahil Kassim, Sharifah Radziah Syed Abd Rahim, Shahnun Ahmad, Atiqah Amran, Lakshman Krishnamurthy
Publikováno v:
Clinical pharmacology in drug developmentReferences. 11(9)
The current study aimed to assess the bioequivalence of a new branded azithromycin with the reference formulation. An open-label, randomized, 2-stage, crossover study design was implemented involving 77 healthy volunteers under fasting conditions. Ea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aa4f661c0c276b02372ab707cd54f51
https://pubmed.ncbi.nlm.nih.gov/35394123
https://pubmed.ncbi.nlm.nih.gov/35394123
Autor:
Ka-Liong Tan, Ranald Malcom Ho, Atiqah Amran, Anil Kumar Anand, Ching Yee Tan, Chuei Wuei Leong
Publikováno v:
Clinical pharmacology in drug developmentReferences. 10(12)
A newly developed branded generic of a moxifloxacin (MOX) 400-mg tablet formulation was manufactured prior to this study. A bioequivalence (BE) study was done to assess the pharmacokinetics of the formulation using a randomized, open-label, 2-period
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ef319249753d6e636e8e7aa45ad8756
https://pubmed.ncbi.nlm.nih.gov/34107173
https://pubmed.ncbi.nlm.nih.gov/34107173